Financials

  • Market Capitalization 225.74 M
  • Employee 51
  • Founded 2006
  • CEO N/A
  • Website www.protaratx.com
  • Headquarter New York, United States
  • FIGI BBG001ZLYSH5
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.98
Rapporto prezzo/fatturato
4 659.52

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3535
NERV
Minerva Neurosciences, Inc - Common Stock
4.84 USD-5.65%+1.04%+17.48%+105.96%231.10 M USD
3536
GLSI
Greenwich LifeSciences, Inc. - Common stock
15.67 USD-16.34%-5.83%+20.82%+35.09%230.01 M USD
3569
KROS
Keros Therapeutics, Inc. - common stock
11.03 USD-1.78%-0.81%+11.19%-26.95%218.69 M USD
3570
VYGR
Voyager Therapeutics, Inc. - Common Stock
3.54 USD+2.31%+4.42%+17.22%-23.87%218.13 M USD

Notizie